13058_2018_1055_MOESM7_ESM.jpg (64.3 kB)
Additional file 7: of Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging
figure
posted on 2018-10-25, 05:00 authored by Brooke McKnight, Nerissa Viola-VillegasTable S4. 89Zr-trastuzumab tumor VOI, pSrc (416) densitometry, and pHER2 (Y1221/1222) densitometry values for BT-474. (JPG 64 kb)